Long-term toxic effects of adjuvant chemotherapy in breast cancer. (Q37834884)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21289366%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

review article

1 reference

title

Long-term toxic effects of adjuvant chemotherapy in breast cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21289366%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21289366%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

author name string

H A Azim

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21289366%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

M Colozza

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21289366%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

J Bines

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21289366%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

M J Piccart

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21289366%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

publication date

2 February 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21289366%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21289366%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21289366%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21289366%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

page(s)

1939-1947

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21289366%20AND%20SRC:MED&resulttype=core&format=json

Breast cancer: achievements in adjuvant systemic therapies in the pre-genomic era.

21 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ683

Cancer survival among US whites and minorities: a SEER (Surveillance, Epidemiology, and End Results) Program population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ683

Cardiac toxicity in breast cancer survivors: review of potential cardiac problems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ683

Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ683

Long-term cardiac follow-up in relapse-free patients after six courses of fluorouracil, epirubicin, and cyclophosphamide, with either 50 or 100 mg of epirubicin, as adjuvant therapy for node-positive breast cancer: French adjuvant study group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ683

Late cardiac effects of adjuvant chemotherapy in breast cancer survivors treated on Southwest Oncology Group protocol s8897.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ683

Functional monitoring of anthracycline cardiotoxicity: a prospective, blinded, long-term observational study of outcome in 120 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ683

Phase III trial of liposomal doxorubicin and cyclophosphamide compared with epirubicin and cyclophosphamide as first-line therapy for metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ683

Multicenter randomized phase III study of the cardioprotective effect of dexrazoxane (Cardioxane) in advanced/metastatic breast cancer patients treated with anthracycline-based chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ683

Prevention of high-dose chemotherapy-induced cardiotoxicity in high-risk patients by angiotensin-converting enzyme inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ683

Response of doxorubicin-induced cardiomyopathy to the current management strategy of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ683

Protective effects of carvedilol against anthracycline-induced cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ683

Feasibility and tolerability of sequential doxorubicin/paclitaxel followed by cyclophosphamide, methotrexate, and fluorouracil and its effects on tumor response as preoperative therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ683

Adjuvant docetaxel for node-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ683

Docetaxel With Cyclophosphamide Is Associated With an Overall Survival Benefit Compared With Doxorubicin and Cyclophosphamide: 7-Year Follow-Up of US Oncology Research Trial 9735.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ683

Risk of new primary nonbreast cancers after breast cancer treatment: a Dutch population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ683

Acute myeloid leukemia after breast cancer: a population-based comparison with hematological malignancies and other cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ683

Risk of acute myeloid leukemia and myelodysplastic syndrome in trials of adjuvant epirubicin for early breast cancer: correlation with doses of epirubicin and cyclophosphamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ683

Acute myeloid leukemia and myelodysplastic syndrome after doxorubicin-cyclophosphamide adjuvant therapy for operable breast cancer: the National Surgical Adjuvant Breast and Bowel Project Experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ683

Cyclophosphamide, epirubicin, and Fluorouracil versus dose-dense epirubicin and cyclophosphamide followed by Paclitaxel versus Doxorubicin and cyclophosphamide followed by Paclitaxel in node-positive or high-risk node-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ683

Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ683

Long-term safety of filgrastim (rhG-CSF) administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ683

Cognitive function in breast cancer survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ683

Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ683

Cognitive function and reproductive hormones in adjuvant therapy for breast cancer: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ683

The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: a meta-analysis of the current literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ683

Cognitive function and quality of life after surgery for early breast cancer in North Jutland, Denmark

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ683

Cognitive function after adjuvant treatment for early breast cancer: a population-based longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ683

A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ683

Change in cognitive function after chemotherapy: a prospective longitudinal study in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ683

Effects of surgical and adjuvant therapies for breast cancer on sexuality, cognitive functions, and body weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ683

The cognitive effects of chemotherapy in post-menopausal breast cancer patients: a controlled longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ683

Central and peripheral nervous system toxicity of common chemotherapeutic agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ683

The influence of erythropoietin on cognitive function in women following chemotherapy for breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ683

The effect of modafinil on cognitive function in breast cancer survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ683

A randomised, placebo-controlled, double-blind trial of the effects of d-methylphenidate on fatigue and cognitive dysfunction in women undergoing adjuvant chemotherapy for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ683

Cancer and cancer-therapy related cognitive dysfunction: an international perspective from the Venice cognitive workshop.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ683

Trends in epidemiology and management of breast cancer in developing Arab countries: a literature and registry analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ683

Breast cancer in young women: poor survival despite intensive treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ683

21 January 2018

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ683

Fertility and menopausal outcomes in young breast cancer survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ683

Fertility and adjuvant treatment in young women with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ683

Incidence and prognostic impact of amenorrhea during adjuvant therapy in high-risk premenopausal breast cancer: analysis of a National Cancer Institute of Canada Clinical Trials Group Study--NCIC CTG MA.5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ683

Incidence, time course, and determinants of menstrual bleeding after breast cancer treatment: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ683

The effects of paclitaxel, dose density, and trastuzumab on treatment-related amenorrhea in premenopausal women with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ683

Pregnancy after treatment of breast cancer--a population-based study on behalf of Danish Breast Cancer Cooperative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ683

Safety of pregnancy following breast cancer diagnosis: a meta-analysis of 14 studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ683

Birth outcome in women with breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ683

Birth outcome in women with previously treated breast cancer--a population-based cohort study from Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ683

Breast-feeding after breast cancer: if you wish, madam.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ683

A qualitative investigation of breast cancer survivors' experiences with breastfeeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ683

Effects of breast-conserving therapy on lactation after pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ683

Breastfeeding in breast cancer survivors: Pattern, behaviour and effect on breast cancer outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ683

Sexuality, Intimacy, and Gynecological Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ683

Changes in sexuality and intimacy after the diagnosis and treatment of cancer: the experience of partners in a sexual relationship with a person with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ683

Sexuality after breast cancer: a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ683

Constructions of sexuality and intimacy after cancer: patient and health professional perspectives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ683